Differential Functions of Splicing Factors in Mammary Transformation and Breast Cancer Metastasis.

MYC SR protein TRA2-beta alternative RNA splicing breast cancer metastasis splicing factor triple negative breast cancer

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
26 11 2019
Historique:
received: 03 07 2019
revised: 09 09 2019
accepted: 28 10 2019
entrez: 28 11 2019
pubmed: 28 11 2019
medline: 21 10 2020
Statut: ppublish

Résumé

Misregulation of alternative splicing is a hallmark of human tumors, yet to what extent and how it contributes to malignancy are only beginning to be unraveled. Here, we define which members of the splicing factor SR and SR-like families contribute to breast cancer and uncover differences and redundancies in their targets and biological functions. We identify splicing factors frequently altered in human breast tumors and assay their oncogenic functions using breast organoid models. We demonstrate that not all splicing factors affect mammary tumorigenesis in MCF-10A cells. Specifically, the upregulation of SRSF4, SRSF6, or TRA2β disrupts acinar morphogenesis and promotes cell proliferation and invasion in MCF-10A cells. By characterizing the targets of these oncogenic splicing factors, we identify shared spliced isoforms associated with well-established cancer hallmarks. Finally, we demonstrate that TRA2β is regulated by the MYC oncogene, plays a role in metastasis maintenance in vivo, and its levels correlate with breast cancer patient survival.

Identifiants

pubmed: 31775037
pii: S2211-1247(19)31443-3
doi: 10.1016/j.celrep.2019.10.110
pmc: PMC6936330
mid: NIHMS1544709
pii:
doi:

Substances chimiques

RNA Splicing Factors 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2672-2688.e7

Subventions

Organisme : NIGMS NIH HHS
ID : R43 GM116478
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA034196
Pays : United States
Organisme : NCI NIH HHS
ID : R00 CA178206
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA045508
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA013106
Pays : United States
Organisme : NIH HHS
ID : S10 OD020122
Pays : United States

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Exp Cell Res. 2011 Oct 15;317(17):2503-11
pubmed: 21851817
Cancer Res. 2008 Nov 15;68(22):9525-31
pubmed: 19010929
Cell Rep. 2012 Feb 23;1(2):167-78
pubmed: 22574288
Mol Cell. 2004 Nov 19;16(4):597-607
pubmed: 15546619
Science. 1993 Apr 9;260(5105):219-22
pubmed: 8385799
Cell Rep. 2012 Feb 23;1(2):110-7
pubmed: 22545246
Nat Biotechnol. 2013 Jan;31(1):46-53
pubmed: 23222703
Nat Struct Mol Biol. 2007 Mar;14(3):185-93
pubmed: 17310252
Cancer Cell. 2015 May 11;27(5):617-30
pubmed: 25965569
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Int J Cell Biol. 2013;2013:843781
pubmed: 23935626
Nat Struct Mol Biol. 2012 Jan 15;19(2):220-8
pubmed: 22245967
BMC Cancer. 2015 Dec 16;15:961
pubmed: 26674738
Biochem J. 2009 Jan 1;417(1):15-27
pubmed: 19061484
RNA. 2015 Jan;21(1):75-92
pubmed: 25414008
PLoS One. 2017 Feb 10;12(2):e0171815
pubmed: 28187152
Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9666-70
pubmed: 15210956
RNA. 2018 Oct;24(10):1326-1338
pubmed: 30042172
BMC Med Genomics. 2009 Apr 24;2:18
pubmed: 19393097
J Cell Biochem. 2012 Jul;113(7):2319-29
pubmed: 22345078
Oncogenesis. 2013 Nov 11;2:e79
pubmed: 24217713
Genes Dev. 1998 Jan 1;12(1):55-66
pubmed: 9420331
Cell. 2008 Nov 28;135(5):865-78
pubmed: 19041750
J Virol. 2010 Jul;84(13):6748-59
pubmed: 20427542
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Mol Cell. 2008 Feb 1;29(2):255-62
pubmed: 18243119
Cell. 2002 Oct 4;111(1):29-40
pubmed: 12372298
Nat Protoc. 2012 Mar 01;7(3):562-78
pubmed: 22383036
Sci Rep. 2013;3:1689
pubmed: 23604310
Oncotarget. 2016 Nov 8;7(45):72395-72414
pubmed: 27590350
Annu Rev Biochem. 2003;72:291-336
pubmed: 12626338
Methods. 2003 Jul;30(3):256-68
pubmed: 12798140
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Genes Dev. 2014 Jun 1;28(11):1191-203
pubmed: 24840202
Oncogene. 1999 Jun 17;18(24):3574-82
pubmed: 10380879
Nat Commun. 2012 May 29;3:859
pubmed: 22643886
Breast Cancer Res. 2014 Jun 22;16(3):R66
pubmed: 24953066
J Hematol Oncol. 2018 May 10;11(1):64
pubmed: 29747682
Nature. 1989 Jul 6;340(6228):66-8
pubmed: 2662015
Nature. 2015 Jul 2;523(7558):96-100
pubmed: 25970242
J Cell Biol. 1997 Jul 28;138(2):225-38
pubmed: 9230067
PLoS Genet. 2016 Sep 28;12(9):e1006316
pubmed: 27681373
Elife. 2014 May 6;:e02028
pubmed: 24842991
Genes Dev. 2009 Aug 1;23(15):1737-42
pubmed: 19651985
PLoS One. 2008 Oct 08;3(10):e3369
pubmed: 18841201
EMBO Mol Med. 2013 May;5(5):737-50
pubmed: 23592547
Mol Cell. 2015 Oct 1;60(1):105-17
pubmed: 26431027
Cell Cycle. 2011 Jul 1;10(13):2184-96
pubmed: 21623162
J Cell Biol. 2017 Jul 3;216(7):1993-2009
pubmed: 28592444
Genes Dev. 2000 Dec 15;14(24):3166-78
pubmed: 11124808
Breast Cancer Res Treat. 2003 May;79(1):75-82
pubmed: 12779084
Nat Biotechnol. 2011 Jan;29(1):79-83
pubmed: 21131983
Curr Genomics. 2007 Sep;8(6):398-414
pubmed: 19412439
Mol Cell Biol. 2002 Oct;22(19):6871-82
pubmed: 12215544
J Clin Invest. 2011 Mar;121(3):1064-74
pubmed: 21393860
J Cell Physiol. 2018 Nov;233(11):8930-8939
pubmed: 29856478
Nature. 2010 Jan 21;463(7279):364-8
pubmed: 20010808
Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14694-9
pubmed: 17766436
Nucleic Acids Res. 2019 Jan 8;47(D1):D1056-D1065
pubmed: 30462303
Mol Cell. 2008 Apr 25;30(2):179-89
pubmed: 18439897
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Nat Rev Cancer. 2016 Jul;16(7):413-30
pubmed: 27282250
Int J Biol Sci. 2010 Dec 15;6(7):806-26
pubmed: 21179588
Nature. 2015 Sep 17;525(7569):384-8
pubmed: 26331541
Nat Cell Biol. 2001 Sep;3(9):785-92
pubmed: 11533657
Biochem Biophys Res Commun. 2012 Jan 6;417(1):588-93
pubmed: 22178073
Cell. 1990 Jul 13;62(1):25-34
pubmed: 2163768
Oncotarget. 2017 Sep 18;8(54):92157-92170
pubmed: 29190905
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Clin Chim Acta. 2007 Sep;384(1-2):69-74
pubmed: 17651715
Cancer Res. 2017 Nov 1;77(21):e7-e10
pubmed: 29092928
PLoS Genet. 2011 Aug;7(8):e1002218
pubmed: 21876675
Cell Rep. 2017 Aug 29;20(9):2215-2226
pubmed: 28854369
Mol Cancer Ther. 2017 Dec;16(12):2849-2861
pubmed: 28878028
Wiley Interdiscip Rev RNA. 2018 Jul;9(4):e1476
pubmed: 29693319
Nucleic Acids Res. 2010 Apr;38(6):1964-81
pubmed: 20044351
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15046-51
pubmed: 18818310
Bioinformatics. 2001 Sep;17(9):847-8
pubmed: 11590104
Oncotarget. 2017 Feb 14;8(7):11160-11172
pubmed: 28061449
J Biol Chem. 2008 Jul 18;283(29):20277-87
pubmed: 18499661
Oncogene. 2016 Oct 6;35(40):5304-5316
pubmed: 27041563
Cancer Res. 2006 May 1;66(9):4774-80
pubmed: 16651431
Methods Enzymol. 2006;406:692-701
pubmed: 16472698
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Nat Rev Cancer. 2005 Sep;5(9):675-88
pubmed: 16148884
Genes Dev. 1990 Jul;4(7):1158-71
pubmed: 2145194
Oncogenesis. 2014 Jan 13;3:e84
pubmed: 24418892
Mol Cell. 2013 Apr 25;50(2):223-35
pubmed: 23562324
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Wiley Interdiscip Rev RNA. 2014 Jul-Aug;5(4):445-59
pubmed: 24523246
Mol Cancer Res. 2017 Feb;15(2):165-178
pubmed: 27856957
Nat Struct Mol Biol. 2009 Jun;16(6):670-6
pubmed: 19448617
Cell Rep. 2018 May 15;23(7):2186-2198
pubmed: 29768215
J Biol Chem. 2007 Jul 6;282(27):19844-53
pubmed: 17513303
EMBO J. 2007 Jan 24;26(2):459-67
pubmed: 17183366
Virus Res. 2013 Sep;176(1-2):223-31
pubmed: 23830997
Genes Dev. 2016 Mar 1;30(5):553-66
pubmed: 26944680
Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):E5593-601
pubmed: 25480548
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Oncogene. 2014 May 8;33(19):2478-86
pubmed: 23752180
Genes Dev. 2004 Apr 1;18(7):755-68
pubmed: 15082528
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
J Cell Biol. 2008 Apr 21;181(2):351-65
pubmed: 18426980
Sci Rep. 2019 Aug 20;9(1):12124
pubmed: 31431650
J Cell Biol. 2003 Oct 27;163(2):315-26
pubmed: 14568991
Mol Cell. 2009 Apr 24;34(2):179-90
pubmed: 19394295
EMBO J. 2010 Oct 6;29(19):3286-300
pubmed: 20711167
Nat Cell Biol. 2016 Jan;18(1):132-8
pubmed: 26571211
Bioinformatics. 2011 Nov 1;27(21):3010-6
pubmed: 21896509
PLoS Pathog. 2011 Jul;7(7):e1002127
pubmed: 21779168

Auteurs

SungHee Park (S)

The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.

Mattia Brugiolo (M)

The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.

Martin Akerman (M)

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA; Envisagenics Inc., New York, NY, USA.

Shipra Das (S)

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.

Laura Urbanski (L)

The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA; Graduate Program in Genetics and Development, UConn Health, Farmington, CT, USA.

Adam Geier (A)

Envisagenics Inc., New York, NY, USA.

Anil K Kesarwani (AK)

The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.

Martin Fan (M)

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.

Nathan Leclair (N)

The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA; Graduate Program in Genetics and Development, UConn Health, Farmington, CT, USA.

Kuan-Ting Lin (KT)

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.

Leo Hu (L)

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.

Ian Hua (I)

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.

Joshy George (J)

The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA; Institute for Systems Genomics, UConn Health, Farmington, CT, USA.

Senthil K Muthuswamy (SK)

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA; Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Adrian R Krainer (AR)

Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA. Electronic address: krainer@cshl.edu.

Olga Anczuków (O)

The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA; Institute for Systems Genomics, UConn Health, Farmington, CT, USA; Department of Genetics and Genome Sciences, UConn Health, Farmington, CT, USA. Electronic address: olga.anczukow@jax.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH